ArticleClinical cancer research : an official journal of the American Association for Cancer Research2020

Preclinical and Dose-Finding Phase I Trial Results of Combined Treatment with a TORC1/2 Inhibitor (TAK-228) and Aurora A Kinase Inhibitor (Alisertib) in Solid Tumors.

S Lindsey Davis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.